Key research into the health of transgender and genderless youth in the UK will begin later this year.
Keep up with the latest LGBTQ+News and politics. Sign up for our supporters email newsletter.
This study includes up to 3,000 children and teens whose gender identity was assigned at birth and differed from genders who relied on the national health service for treatment. New York Times Report. Researchers will consider the physical, mental and social health of participants.
This will be funded by the NHS and the UK government’s clinical research institutes, and King’s College London will be implemented by King’s College London to determine how the NHS will serve the best service for this population.
“Involvement in this study is voluntary and will inherently be observed. That is, researchers will not change the treatments children are receiving.” The era Note. “Researchers will investigate individuals and their parents or caretakers over several years without providing additional interventions.”
This study comes at a time when gender-maintaining care is under attack in the UK. Last year, it banned the provision of adolescent blockers for people under the age of 18, except for participants in clinical trials following a review by pediatrician Hilary Cass. However, her reviews have been widely criticized.
For example, medical groups from Germany, Austria and Switzerland came together to release guidelines to support this care. They argued that Cass reviews were full of methodological flaws and misrepresentations. Trans rights groups added that they have set higher standards for evidence of the effectiveness of gender-maintaining care than other treatments.
Related: Hilary Cass ‘NHS Report reveals theory and falsehood
After the review was published, the NHS closed its only UK clinic and opened several local ones that aim to provide gender care to young people, focusing on mental health and take a holistic approach to gender discomfort. This study examines the care provided by these centers.
Emily Saimonov, a professor of children and adolescent psychiatry at King’s College, said he will become the lead investigator for the study. The era It helps to solve gender-maintaining care questions. “What we’ve heard from young people, their parents and caregivers is that they are concerned about the lack of robust evidence to guide the treatment that is most useful to them. She said, “The lack of evidence base allows us to ramp out more of the toxic view.”
“What is clear from the current evidence highlighted is that there is no single story or experience that defines these youths,” said Michael Abdeau, a lead investigator. “This research is about listening to their stories: understanding their stories and journeys and building a robust evidence base that reflects their diversity,” he added.
However, there is much evidence about the effectiveness of gender-maintaining care, and it has been approved in the US by all major medical associations.
Some supporters of this care welcomed the study. “The investment in research and clinical trials should be praised,” said Scott Leibowitz, a US child and adolescent psychiatrist on the board of the World Professional Association for Transgender Health. The era. However, he is concerned about the impact of adolescent blocker bans on young people in the UK
King’s College is also planning to study adolescent blockers. In this study, participants are able to receive treatment despite the ban, but still awaits regulatory approval.
Source: Advocate.com – www.advocate.com
